Alterola Biotech Inc
OTC:ABTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (12.5), the stock would be worth $-0.02 (447% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -3.6 | $0.01 |
0%
|
| Industry Average | 12.5 | $-0.02 |
-447%
|
| Country Average | 19.6 | $-0.03 |
-644%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Alterola Biotech Inc
OTC:ABTI
|
7.5m USD | -3.6 | -3.6 | |
| FR |
|
L'Oreal SA
PAR:OR
|
200.6B EUR | 22.2 | 32.4 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
92.3B GBP | 12.8 | 11.2 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.6T INR | 39.7 | 37.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.3B GBP | 15 | 18.7 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.6B USD | 22.7 | -155.2 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
16B EUR | 9.8 | 16.9 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 14.8 | 22.2 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR | 42.2 | 64.1 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -6 360.4 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
815.9B INR | 38.8 | 43.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Alterola Biotech Inc
Glance View
Alterola Biotech, Inc. develops medical cannabis products. The company is headquartered in Walnut, California. The company went IPO on 2010-03-09. The firm is focused on developing pharmaceutical medicines made from cannabinoid, cannabinoid-like and non-cannabinoid active pharmaceutical ingredients (APIs) globally. The company is also focused on developing non-pharmaceutical (nutraceutical / dietary supplement) products containing cannabinoids, cannabinoid-like and non-cannabinoid food-grade ingredients. In addition, the Company is focused on supplying cosmetic ingredients to potential customers who develops products containing cannabinoids, cannabinoid-like and non-cannabinoid ingredients.
